precision semaglutide Compounded GLP-1 - & Tirzepatide FDA Warns on Certain Forms

My team and I set out to test whether GLP-1 drugs medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for obesity could do what no existing addiction treatment does: curb craving itself

Clinicians may consider this when tailoring a prescription plan to individual needs

However, evidence supporting micronutrient interventions to attenuate obesity-induced oxidative stress in the male reproductive system is limited

This does not mean compounded semaglutide is unsafe

and was brought to market for individuals living with type 2 diabetes